Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
2-((5R,8S,11S,14S,17S,20S,23S,29S,32S,35S,38R,41R,44R)-29,35-bis((1H-indol-3-yl)methyl)-44-amino-20,32-bis(3-guanidinopropyl)-5,11,38-tris(4-hydroxybenzyl)-17-((R)-1-hydroxyethyl)-41-((S)-1-hydroxyethyl)-23-(hydroxymethyl)-8-isopropyl-2,4,7,10,13,16,19,22,25,28,31,34,37,40,43-pentadecaoxo-1-thia-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaazacyclopentatetracontan-14-yl)acetamide
ID: ALA4532618
PubChem CID: 155547264
Max Phase: Preclinical
Molecular Formula: C87H114N24O22S
Molecular Weight: 1880.08
Molecule Type: Unknown
Associated Items: